X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4196) 4196
Publication (424) 424
Book Review (42) 42
Book Chapter (23) 23
Dissertation (18) 18
Conference Proceeding (10) 10
Data Set (3) 3
Magazine Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3217) 3217
index medicus (1999) 1999
cytochrome p-450 cyp2c19 (1925) 1925
cyp2c19 (1758) 1758
pharmacology & pharmacy (1733) 1733
male (1678) 1678
female (1503) 1503
genotype (1463) 1463
aryl hydrocarbon hydroxylases - genetics (1208) 1208
middle aged (1104) 1104
adult (1047) 1047
pharmacogenetics (882) 882
clopidogrel (837) 837
cytochrome p-450 (785) 785
polymorphism, genetic (766) 766
aged (747) 747
pharmacokinetics (741) 741
metabolism (733) 733
ticlopidine - analogs & derivatives (720) 720
cytochrome p-450 cyp2c19 - genetics (636) 636
mixed function oxygenases - genetics (593) 593
polymorphism (592) 592
aryl hydrocarbon hydroxylases - metabolism (547) 547
omeprazole (533) 533
phenotype (501) 501
cytochrome p-450 enzyme system - metabolism (490) 490
cyp2c19 genotype (466) 466
genetic aspects (455) 455
cytochrome p-450 enzyme system - genetics (444) 444
mixed function oxygenases - metabolism (444) 444
alleles (443) 443
aryl hydrocarbon hydroxylases (439) 439
proton pump inhibitors (436) 436
platelet aggregation inhibitors - therapeutic use (416) 416
drug interactions (415) 415
treatment outcome (404) 404
ticlopidine - therapeutic use (388) 388
cyp2d6 (373) 373
genetic polymorphisms (372) 372
percutaneous coronary intervention (350) 350
analysis (319) 319
cytochrome p-450 cyp2d6 - genetics (318) 318
cytochrome p450 (317) 317
young adult (315) 315
cytochrome p-450 cyp2c9 (298) 298
hydroxylation (297) 297
research (297) 297
polymorphisms (292) 292
lansoprazole (289) 289
polymorphism, single nucleotide (284) 284
adolescent (275) 275
risk factors (268) 268
cardiac & cardiovascular systems (265) 265
enzymes (265) 265
gene frequency (264) 264
cytochrome p-450 cyp2c19 - metabolism (256) 256
in-vitro (254) 254
rabeprazole (251) 251
toxicology (240) 240
pharmacology (237) 237
platelet reactivity (234) 234
physiological aspects (231) 231
cyp2c9 (229) 229
pharmacogenomics (229) 229
s-mephenytoin (227) 227
population (226) 226
therapy (226) 226
genetics & heredity (224) 224
drug therapy, combination (221) 221
identification (220) 220
metabolites (220) 220
risk (218) 218
area under curve (211) 211
aspirin (211) 211
abridged index medicus (208) 208
platelet aggregation - drug effects (208) 208
dose-response relationship, drug (207) 207
asian continental ancestry group - genetics (205) 205
antiplatelet therapy (203) 203
aged, 80 and over (199) 199
microsomes, liver - enzymology (199) 199
prasugrel (199) 199
genetic-polymorphism (197) 197
cytochrome p-450 cyp2d6 - metabolism (195) 195
ticlopidine - pharmacology (194) 194
care and treatment (193) 193
pharmacology/toxicology (191) 191
article (190) 190
helicobacter pylori (190) 190
gastroenterology & hepatology (189) 189
of-function polymorphism (188) 188
animals (187) 187
genetic polymorphism (187) 187
human liver-microsomes (187) 187
ticlopidine - administration & dosage (186) 186
prospective studies (185) 185
cytochrome p-450 cyp3a (184) 184
platelet aggregation inhibitors - pharmacology (184) 184
polymerase chain reaction (183) 183
drug therapy (182) 182
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3964) 3964
Japanese (67) 67
Russian (42) 42
Chinese (41) 41
German (27) 27
Spanish (20) 20
Korean (19) 19
French (15) 15
Polish (6) 6
Portuguese (6) 6
Hungarian (4) 4
Norwegian (4) 4
Czech (2) 2
Danish (2) 2
Greek (2) 2
Italian (2) 2
Dutch (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 03/2019, Volume 105, Issue 3, pp. 547 - 549
Genetics has given a real boost to personalized and precision medicine, providing data used either for precise diagnostics, prediction of the course of... 
PHARMACOLOGY & PHARMACY | CYP2C19 POLYMORPHISMS
Journal Article
CLINICAL PHARMACOLOGY & THERAPEUTICS, ISSN 0009-9236, 02/2018, Volume 103, Issue 2, pp. 187 - 187
Journal Article
American Journal of Emergency Medicine, ISSN 0735-6757, 2019
Introduction: Citalopram is a selective serotonin reuptake inhibitor used for treatment of depression. Metabolism is primarily through CYP3A4 and CYP2C19;... 
Serotonin syndrome | CYP2C19 | Metabolism | Citalopram
Journal Article
Journal Article
AMERICAN JOURNAL OF GASTROENTEROLOGY, ISSN 0002-9270, 08/2016, Volume 111, Issue 8, pp. 1204 - 1205
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2012, Volume 59, Issue 22, pp. 1928 - 1937
Journal Article
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2017, Volume 23, Issue 11, pp. 2060 - 2067
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 12/2018, Volume 74, Issue 12, pp. 1567 - 1574
Clopidogrel non-responsiveness is multifactorial; several genetic and non-genetic factors may contribute to impaired platelet inhibition. The goal of this... 
Clopidogrel | Biomedicine | Pharmacology/Toxicology | Cytochrome P-450 CYP2C19 | Coronary artery disease | Diabetes mellitus | RESPONSE VARIABILITY | CYP2C19 GENOTYPE | CARDIOVASCULAR OUTCOMES | STENT THROMBOSIS | OF-FUNCTION POLYMORPHISM | VERIFYNOW P2Y12 ASSAY | DUAL ANTIPLATELET THERAPY | PHARMACOLOGY & PHARMACY | ELEVATION MYOCARDIAL-INFARCTION | PLATELET REACTIVITY | CLINICAL-OUTCOMES | Cross-Sectional Studies | Diabetes Mellitus - genetics | Humans | Middle Aged | Diabetes Mellitus - drug therapy | Cytochrome P-450 CYP2C19 - genetics | Genotype | Male | Coronary Artery Disease - drug therapy | Diabetic Angiopathies - drug therapy | Polymorphism, Genetic | Young Adult | Coronary Artery Disease - complications | Coronary Artery Disease - genetics | Platelet Function Tests | Adult | Cytochrome P-450 CYP2C19 - metabolism | Female | Heterozygote | Aged | Blood Platelets - drug effects | Clopidogrel - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Medical research | Care and treatment | Analysis | Cardiac patients | Cytochrome P-450 | Medicine, Experimental | Genetic aspects | Diabetes | Cardiology | Coronary heart disease | Cytochrome | Clinical trials | Cardiovascular disease | Gene polymorphism | Confidence intervals | Blood platelets | Genetic factors | Inhibition | Heart diseases | Cytochromes P450 | Risk groups | Cytochrome P450 | Coronary artery | Patients | Polymerase chain reaction | Restriction fragment length polymorphism | Genotyping | Coronary vessels | Alleles | Platelets | Polymorphism
Journal Article